相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo
Federica Albanese et al.
NEUROBIOLOGY OF DISEASE (2021)
Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Linn Streubel-Gallasch et al.
MOLECULAR NEUROBIOLOGY (2021)
LRRK2 Ablation Attenuates Αlpha-Synuclein-Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo
Anke Van der Perren et al.
NEUROTHERAPEUTICS (2021)
Genetic background influences LRRK2-mediated Rab phosphorylation in the rat brain
Kaela Kelly et al.
BRAIN RESEARCH (2021)
Astrocytic atrophy as a pathological feature of Parkinson's disease with LRRK2 mutation
Paula Ramos-Gonzalez et al.
NPJ PARKINSONS DISEASE (2021)
Imaging of translocator protein upregulation is selective for pro-inflammatory polarized astrocytes and microglia
Maria Pannell et al.
GLIA (2020)
G2019S-LRRK2 mutation enhances MPTP-linked Parkinsonism in mice
Nicolas Arbez et al.
HUMAN MOLECULAR GENETICS (2020)
Lysosome and Inflammatory Defects in GBA1-Mutant Astrocytes Are Normalized by LRRK2 Inhibition
Anwesha Sanyal et al.
MOVEMENT DISORDERS (2020)
LRRK2 in Parkinson disease: challenges of clinical trials
Eduardo Tolosa et al.
NATURE REVIEWS NEUROLOGY (2020)
Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration
Zach Dwyer et al.
NEUROBIOLOGY OF AGING (2020)
LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease
Emily M. Rocha et al.
NEUROBIOLOGY OF DISEASE (2020)
Sodium Butyrate Exacerbates Parkinson's Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model
Chen-Meng Qiao et al.
NEUROCHEMICAL RESEARCH (2020)
Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity
An Phu Tran Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Translation Imaging in Parkinson's Disease: Focus on Neuroinflammation
Sara Belloli et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration
Eunju Lee et al.
CELL DEATH AND DIFFERENTIATION (2019)
LRRK2 inhibition does not impart protection from -synuclein pathology and neuron death in non-transgenic mice
Michael X. Henderson et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function
Rebecca Wallings et al.
HUMAN MOLECULAR GENETICS (2019)
The role of monogenic genes in idiopathic Parkinson's disease
Xylena Reed et al.
NEUROBIOLOGY OF DISEASE (2019)
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes
Daniela Mercatelli et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis
Sara Belloli et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Clustering of Motor and Nonmotor Traits in Leucine-Rich Repeat Kinase 2 G2019S Parkinson's Disease Nonparkinsonian Relatives: A Multicenter Family Study
Tiago A. Mestre et al.
MOVEMENT DISORDERS (2018)
Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation
Michael Aagaard Andersen et al.
NEUROBIOLOGY OF DISEASE (2018)
Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons
Jason Schapansky et al.
NEUROBIOLOGY OF DISEASE (2018)
Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice
Yulan Xiong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Neuronal Dysfunction and Behavioral Abnormalities Are Evoked by Neural Cells and Aggravated by Inflammatory Microglia in Peroxisomal beta-Oxidation Deficiency
Lien Beckers et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease
Alessandro Tozzi et al.
CELL DEATH & DISEASE (2018)
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
Michael X. Henderson et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
The G2019S mutation in LRRK2 imparts resiliency to kinase inhibition
Kaela Kelly et al.
EXPERIMENTAL NEUROLOGY (2018)
G2019S LRRK2 mutation facilitates alpha-synuclein neuropathology in aged mice
Salvatore Novello et al.
NEUROBIOLOGY OF DISEASE (2018)
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity
Jillian H. Kluss et al.
NPJ PARKINSONS DISEASE (2018)
Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease
Andrew B. West
EXPERIMENTAL NEUROLOGY (2017)
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity
Jack D. Scott et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis
Heather D. E. Booth et al.
TRENDS IN NEUROSCIENCES (2017)
Tipping Points and Endogenous Determinants of Nigrostriatal Degeneration by MPTP
Stefan Schildknecht et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson's Disease Mouse Model
Hien Tran Zhao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice
Francesco Longo et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells
Kenneth Thirstrup et al.
SCIENTIFIC REPORTS (2017)
LRRK2 mouse models: dissecting the behavior, striatal neurochemistry and neurophysiology of PD pathogenesis
Mattia Volta et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
TMEM119 marks a subset of microglia in the human brain
Jun-ichi Satoh et al.
NEUROPATHOLOGY (2016)
Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors
Genta Ito et al.
BIOCHEMICAL JOURNAL (2016)
LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1-mediated signalling pathways
Bo Ma et al.
HUMAN MOLECULAR GENETICS (2016)
LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity
Senthilkumar S. Karuppagounder et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2016)
Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
Abid Oueslati
JOURNAL OF PARKINSONS DISEASE (2016)
Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression
Anastasia G. Henry et al.
HUMAN MOLECULAR GENETICS (2015)
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
Joao P. L. Daher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
Isabella Russo et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
M. Yue et al.
NEUROBIOLOGY OF DISEASE (2015)
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
Reina N. Fuji et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease
Lorraine V. Kalia et al.
JAMA NEUROLOGY (2015)
Radiosynthesis and Preliminary Biological Evaluation of [18F]VC701, a Radioligand for Translocator Protein
Giuseppe Di Grigoli et al.
MOLECULAR IMAGING (2015)
Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), A Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor
Jaclyn L. Henderson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibitions
Matthew J. Fell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction
Laurie H. Sanders et al.
NEUROBIOLOGY OF DISEASE (2014)
Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging
Francesco Longo et al.
NEUROBIOLOGY OF DISEASE (2014)
Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats
Joao P. L. Daher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice
Dayne A. Beccano-Kelly et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization
Rossana Migheli et al.
PLOS ONE (2013)
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Mark S. Moehle et al.
JOURNAL OF NEUROSCIENCE (2012)
LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors
Kelly M. Hinkle et al.
MOLECULAR NEURODEGENERATION (2012)
Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease
Oliver Cooper et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
Martin C. Herzig et al.
HUMAN MOLECULAR GENETICS (2011)
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
Janelle Drouin-Ouellet et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Xianming Deng et al.
NATURE CHEMICAL BIOLOGY (2011)
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
Nicolas Dzamko et al.
BIOCHEMICAL JOURNAL (2010)
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Byoung Dae Lee et al.
NATURE MEDICINE (2010)
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
Chen Yao et al.
NEUROBIOLOGY OF DISEASE (2010)
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
Heather Mortiboys et al.
NEUROLOGY (2010)
Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review
L. Correia Guedes et al.
PARKINSONISM & RELATED DISORDERS (2010)
Unexpected Lack of Hypersensitivity in LRRK2 Knock-Out Mice to MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine)
Eva Andres-Mateos et al.
JOURNAL OF NEUROSCIENCE (2009)
Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein
Xian Lin et al.
NEURON (2009)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
From bone marrow to microglia: barriers and avenues
Nathalie Davoust et al.
TRENDS IN IMMUNOLOGY (2008)
Bone-marrow-derived cell differentiation into microglia:: A study in a progressive mouse model of Parkinson's disease
Manuel Rodriguez et al.
NEUROBIOLOGY OF DISEASE (2007)
Dynamic and redundant regulation of LRRK2 and LRRK1 expression
Saskia Biskup et al.
BMC NEUROSCIENCE (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy
Y Ma et al.
NEUROSCIENCE (2005)
Pathogenic role of glial cells in Parkinson's disease
P Teismann et al.
MOVEMENT DISORDERS (2003)
Animal models of Parkinson's disease
R Betarbet et al.
BIOESSAYS (2002)
分享论文
